Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Cash Flow-to-Debt Ratio
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥22.69 Million could theoretically repay 0% of its total liabilities (CN¥2.09 Billion) in one year. See financial agility of Henan Taloph Pharmaceutical Stock Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Henan Taloph Pharmaceutical Stock Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Henan Taloph Pharmaceutical Stock Co Ltd.
Annual Cash Flow-to-Debt Ratio for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Henan Taloph Pharmaceutical Stock Co Ltd. Check Henan Taloph Pharmaceutical Stock Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥47.16 Million | CN¥1.98 Billion | ▲ +212.2% |
| 2024 | -0.02x | CN¥-39.59 Million | CN¥1.86 Billion | ▼ -194.9% |
| 2023 | 0.02x | CN¥43.74 Million | CN¥1.95 Billion | ▲ +135.7% |
| 2022 | -0.06x | CN¥-124.41 Million | CN¥1.99 Billion | ▼ -226.1% |
| 2021 | 0.05x | CN¥99.66 Million | CN¥2.01 Billion | ▲ +25.8% |
| 2020 | 0.04x | CN¥73.43 Million | CN¥1.86 Billion | ▲ +35.8% |
| 2019 | 0.03x | CN¥41.53 Million | CN¥1.43 Billion | ▼ -64.8% |
| 2018 | 0.08x | CN¥119.47 Million | CN¥1.44 Billion | ▲ +364.2% |
| 2017 | 0.02x | CN¥23.17 Million | CN¥1.30 Billion | ▼ -70.9% |
| 2016 | 0.06x | CN¥70.60 Million | CN¥1.15 Billion | ▲ +42.0% |
| 2015 | 0.04x | CN¥49.27 Million | CN¥1.14 Billion | ▼ -46.6% |
| 2014 | 0.08x | CN¥89.54 Million | CN¥1.11 Billion | ▲ +1149.2% |
| 2013 | -0.01x | CN¥-6.65 Million | CN¥861.22 Million | ▼ -108.1% |
| 2012 | 0.10x | CN¥87.45 Million | CN¥912.93 Million | ▲ +75588.3% |
| 2011 | 0.00x | CN¥105.20K | CN¥831.28 Million | ▲ +100.4% |
| 2010 | -0.03x | CN¥-20.00 Million | CN¥641.92 Million | ▼ -173.6% |
| 2009 | 0.04x | CN¥21.45 Million | CN¥506.12 Million | ▼ -10.9% |
| 2008 | 0.05x | CN¥18.13 Million | CN¥381.43 Million | ▼ -28.0% |
| 2007 | 0.07x | CN¥21.34 Million | CN¥323.29 Million | ▲ +1234.1% |
| 2006 | 0.00x | CN¥1.59 Million | CN¥322.24 Million | ▲ +398.9% |
| 2005 | 0.00x | CN¥276.30K | CN¥278.70 Million | ▼ -98.5% |
| 2004 | 0.06x | CN¥18.25 Million | CN¥283.44 Million | ▲ +362.1% |
| 2003 | 0.01x | CN¥3.74 Million | CN¥268.36 Million | ▼ -50.6% |
| 2002 | 0.03x | CN¥7.47 Million | CN¥264.70 Million | ▼ -89.4% |
| 2001 | 0.27x | CN¥55.03 Million | CN¥206.07 Million | ▲ +4855.7% |
| 2000 | 0.01x | CN¥875.36K | CN¥162.45 Million | ▼ -99.2% |
| 1999 | 0.66x | CN¥99.32 Million | CN¥151.10 Million | ▲ +286.3% |
| 1998 | 0.17x | CN¥28.04 Million | CN¥164.79 Million | — |